Monday, February 11, 2008

Fwd: LegalView's Newest Practice Area Provides Insight Controversy Surrounding Smoking Cessation Drug Chantix (PRWeb)



---------- Forwarded message ----------
From: Shell Enfesta <mesothelioma77@gmail.com>
Date: Feb 11, 2008 4:53 PM
Subject: Fwd: LegalView's Newest Practice Area Provides Insight Controversy Surrounding Smoking Cessation Drug Chantix (PRWeb)
To: mesothelioma77.mesothelioma03@blogger.com




---------- Forwarded message ----------
From: Yahoo! News Search Results for mesothelioma <rssfwd@rssfwd.com>
Date: Feb 10, 2008 5:03 PM
Subject: LegalView's Newest Practice Area Provides Insight Controversy Surrounding Smoking Cessation Drug Chantix (PRWeb)
To: mesothelioma77@gmail.com


LegalView launched a new practice area regarding the controversial drug that is used to help smokers quit, but may be in fact be causing suicidal tendencies and behaviors in patients. (PRWeb Feb 10, 2008) Read the full story at http://www.prweb.com/releases/2008/02/prweb688923.htm

Sun, 10 Feb 2008 08:20:05 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/mesothelioma/SIG=11pqejlpo/*http%3A//www.prweb.com/releases/2008/02/prweb688923.htm
--
 ~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc